About Immunome (IMNM)
Immunome, Inc. is a biotechnology company engaged in developing targeted cancer therapies. The Company’s portfolio pursues each target with a modality appropriate to its biology, including immunotherapies, targeted effectors, radioligand therapies an... Read more
- USD10.80
- USD10.80
- USD10.24
- USD16.73
- 22.70%
- 11M
- 538.26k
- 995.10k
- 921M
- 5.15
- -12.20%
Stock News
3 hours ago
United Airlines sees massive delays after hundreds of U.S. flights grounded due to technical issue
MarketWatch
5 hours ago
United Fire Group, Inc. 2025 Q2 - Results - Earnings Call Presentation
SeekingAlpha
yesterday
Jim Cramer on Wednesday's action: 'We have a market that’s all over the map'
CNBC
yesterday
Firefly Aerospace prices shares at $45, above the expected range
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
